Provided by: ASiM - Gout is increasing in both incidence and severity. Treatment adherence issues on allopurinol alone and resistant gout lead to failed target serum uric acid concentration. There are new and emerging agents, including xanthine oxidase inhibitors, uricosuric agents, uricase agents, and interleukin 1 inhibitorsdrugs that can provide alternatives to allopurinol alone. It is in...

Provided by: ASiM - Current options for Parkinson disease (PD) pharmacotherapy include levodopa, monoamine oxidase B inhibitors, and dopamine agonists, which address only the symptoms of PD. Although there are no definitive data to show that any of these agents affect disease progression, the publication of the TEMPO and ADAGIO studies of rasagiline suggested (but did not prove) that some of th...

Provided by: ASiM - Diabetic macular edema (DME) is the major cause of vision loss in people with diabetic retinopathy. In recent years, results from several clinical trials have been published including the Diabetic Retinopathy Clinical Research Networks Protocol H trial, the READ-2 trial, the RESOLVE trial, Protocol I trial, RESTORE, and FAME. Furthermore, new delivery system t...

Provided by: ASiM - Osteoporosis is a disease of the skeletal system characterized by decreased bone mass and impaired bone strength, resulting in an increased risk of fracture. It is a prevalent disease and with the increasing elderly population, it is rapidly becoming a major public health concern. Approximately half of the adults diagnosed with osteoporosis still remain untreated with pharma...

Provided by: ASiM - Ocular surface diseases are important public health issues that have negative impacts on the quality of life and productivity of patients. Because they are more common in older individuals and largely perceived as female diseases, patients from different demographics are frequently underdiagnosed. Furthermore, statistics conclude that eye care professionals underappreciate t...

Provided by: Primary Issues - Learning Objectives After participating in this educational activity, participants should be better able to Recognize the common and less common signs and symptoms of thyroid disorders and have a low index of suspicion for patient work-up Prescribe thyroid replacement therapy according to relevant guidelines, and follow up with patients regularly, adapting ...

Provided by: Primary Issues - Learning Objectives After participating in this educational activity, participants should be better able to Evaluate the etiology of heavy menstrual bleeding (HMB) in order to initiate appropriate treatment or referral. Identify available therapies and treatment strategies for patients with HMB, considering etiology, risks/benefits, and individual patient nee...

Provided by: ASiM - OVERVIEW Notable changes have affected the practice of managing patients with pain. Sadly, treatment of patients with both acute and chronic pain remains strikingly inadequate, regardless of a better understanding of the underlying pathology and a growing range of therapies. Pain is one of the most common reasons patients seek medical attention. When pain has no cure and is...

Provided by: ASiM - The goals of our intervention would be to give the primary care provider a better understanding of the physiology of neuropathic pain; the skills and tools to better screen patients for pain and complications of mismanaged pain and when properly identified, know how to safely and effectively treat their pain. Performance Improvement CME (PI-CME) was developed to help hea...

Provided by: Impact Education, LLC - Target Audience This activity has been designed to meet the educational needs of: - Psychiatrists, primary care physicians, and other clinicians involved with the care of adult patients with major depressive disorder (MDD) - Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, publ...